Lung cancer incidences increase in women, say experts at Neuberg Centre for Genomic Medicine

In a new study, researchers at the University of Illinois at Urbana-Champaign explored the use of microplasma — a highly focused stream of chemically excited ions and molecules —  for attacking the bacterial biofilms that resist antibiotic treatment in the middle ear. Their findings were published  in the journal npj Biofilms and Microbiome

The U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.

A study based in Taiwan found that administering telmisartan, a medication used to treat high blood pressure, heart failure, and diabetic kidney disease reduces the risk of dementia and ischemic stroke in hypertensive (HT) patients with type 2 diabetes mellitus (T2DM).

The U.S. Food and Drug Administration (USFDA) has approved the immunotherapy drug pembrolizumab (Keytruda) as a treatment for patients with high-risk early-stage triple-negative breast cancer (TNBC) in combination with chemotherapy, announced the pharmaceutical company Merck & Co Inc.

A study conducted by researchers in Egypt has found that multiple myeloma patients mount variable and sometimes suboptimal responses after receiving the Pfizer-BioNTech or Moderna COVID-19 vaccines.

Signs of nerve damage in the cells of the surface of the eyes can help identify patients likely to suffer from ‘long Covid’, according to a new study conducted by researchers from Turkey and Qatar. The study was  published in the British Journal of Ophthalmology.